Heart rate modulation in stable coronary artery disease without clinical heart failure: What we have already learned from SIGNIFY?

about

Heart rate modulation in stable coronary artery disease without clinical heart failure: What we have already learned from SIGNIFY?

Item

http://www.wikidata.org/entity/Q53780458

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Heart rate modulation in stabl ...... already learned from SIGNIFY?

@en

Heart rate modulation in stabl ...... already learned from SIGNIFY?

@nl

type

Item

label

Heart rate modulation in stabl ...... already learned from SIGNIFY?

@en

Heart rate modulation in stabl ...... already learned from SIGNIFY?

@nl

prefLabel

Heart rate modulation in stabl ...... already learned from SIGNIFY?

@en

Heart rate modulation in stabl ...... already learned from SIGNIFY?

@nl

P1476

Heart rate modulation in stabl ...... already learned from SIGNIFY?

@en

P2093

Claudio Rapezzi

http://www.w3.org/2001/XMLSchema#string

Fabio Vagnarelli

http://www.w3.org/2001/XMLSchema#string

Gian Piero Perna

http://www.w3.org/2001/XMLSchema#string

Ilaria Battistoni

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Effects of intensive glucose lowering in type 2 diabetes

Funny channels in the control of cardiac rhythm and mode of action of selective blockers.

Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.

Optimal medical therapy with or without PCI for stable coronary disease.

Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study.

Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial.

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Resting heart rate in cardiovascular disease.

P304

58-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CONCTC.2016.06.003

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maurizio Volterrani

P577

2016-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29736470

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

P932

5935893

http://www.w3.org/2001/XMLSchema#string